Building the next generation of biotech ventures

Welcome to BaseLaunch

We partner with scientists and entrepreneurs to help launch and grow exceptional biotech companies developing cutting-edge therapeutics. And we know how to do this – so far our portfolio has raised over $160M in venture financing with an average raise of $28M per company.

Up to $500,000
in financing

Access to our partners,
global biopharma & investors

Company & team
build out

Access to labs &
related infrastructure
where needed

Partners

We are very pleased to continue our commitment to BaseLaunch. Basel has always been home to great ideas and innovation and today it is a leading life sciences hub within Switzerland and globally.

James SabryGlobal Head of Roche Pharma Partnering

We are delighted to join BaseLaunch as a partner in the next phase of its company building activities. The Pureos team worked closely with BaseLaunch during the Series A funding of Alentis Therapeutics and has been very impressed by the team and the quality of the selected programs.

Anja HarmeierPartner at BB Pureos Bioventures

We are proud to continue our partnership with BaseLaunch and support its mission of building companies that deliver innovative medicines to patients.

Sascha BucherHead of Global Transactions at Roivant Sciences

In joining BaseLaunch, centered in the Basel Area, a major hub for life sciences innovation in Europe, our team is very excited to explore new opportunities of discovering promising therapeutic ventures and supporting exceptional seed-stage biotech companies developing sciences into novel therapeutics.

James LeeCEO at Bridge Biotherapeutics

This partnership will help us identify and build relationships with potential external collaborators from throughout Europe…

Dr. Adrian ZuercherVice President, Research Europe and Head of Plasma Protein Research, CSL Behring

Incubators and accelerators are central to the global healthcare start-up ecosystem. We have been collaborating with BaseLaunch since launch in supporting the growth and development of early-stage biotech ventures and recognize the contribution the team has made towards achieving their goals...

Nerida ScottHead, Johnson & Johnson Innovation

Application cycle is now open!

Last deadline for 2020 is October 25